JK
Joshua Kennedy-Smith
Partner at RTW Investments
JK
Joshua Kennedy-smith
Partner at RTW Investments
New York, New York
Overview
Joshua Kennedy-Smith is a Partner at RTW Investments, LP in New York, New York, with a background in drug discovery and medicinal chemistry. He has held significant roles at Schrödinger and Hoffmann-La Roche, showcasing expertise in lead generation and drug design in the pharmaceutical industry.
Work Experience
Partner
2024 - Current
Managing Director
2019 - 2024
Research Analyst
2016 - 2019
RTW Investments makes investments in forward-thinking healthcare companies.
Senior Principal Scientist
2013 - 2015
Schrödinger is a healthcare-based software company that develops molecular design software for biotech and materials research.
Raised $577,224,987.00 from Bill & Melinda Gates Foundation and Bill & Melinda Gates Foundation.
Senior Scientist
2009 - 2013
Global Assignee
2012 - 2012
Research Scientist
2005 - 2009
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on